Dr. Maria K. Houtchens, MD

Dr. Houtchens practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Houtchens' NPI, 1740262021, was assigned on November 14, 2005. Dr. Houtchens graduated from University of Utah School of Medicine in 1999. Dr. Houtchens holds Massachusetts license 217256.

Dr. Houtchens' primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Houtchens' primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Houtchens is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Houtchens to 2 more group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Houtchens practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Houtchens' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Houtchens is licensed in Massachusetts.

CMS data shows 110 Medicare services from Dr. Houtchens across 4 procedure codes in 2024, for 96 Medicare patients. Medicare paid $7,370 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. Houtchens in 2024. The largest group is 65 to 74, with 45 patients. 68% of them have high cholesterol, and 59% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Houtchens' median patient age at 63, with 75% women.

In 2024, Dr. Houtchens wrote 622 Medicare Part D claims for 79 patients. 69% of them were for generic drugs. CMS names the drug for 495 of them, across 19 drugs with 11 or more claims each, at $1,525,094 in total drug cost. In 2023, CMS named 694 claims across 22 drugs.

Dr. Houtchens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Houtchens as offering telehealth.

CMS Open Payments shows 322 general payments to Dr. Houtchens from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Sanofi and Genzyme US Companies paid the most, $140,791. It also lists 4 research payments totaling $7,124 from 2023 to 2025.

Dr. Houtchens graduated from University of Utah School of Medicine in 1999.